SCHEMBL7986249

SCHEMBL7986249

CC(C)(C)OC(=O)Nc1cccc(CCCOS(C)(=O)=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ MMP1 P03956 1/20 0.42
▸ MMP2 P08253 1/20 0.42
▸ MMP9 P14780 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ KAT6A Q92794 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ GLS O94925 1/20 0.41
▸ RORC P51449 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025361 0.93 CYP3A4 (0.46) CYP3A4CYP2C19CA1CA2AURKA
SCHEMBL5390555 0.85 CYP17A1 (0.49) CA1CA2NPC1RECQLRAB9A
SCHEMBL1025076 0.85 SIRT2 (0.48) CYP3A4CYP2C19CA1CA2AURKA
SCHEMBL27399236 0.83 TLR7 (0.54) CYP3A4CYP2C19NPC1RAB9ASMN1; SMN2
SCHEMBL7972399 0.83 CYP3A4 (0.48) CYP3A4CYP2C19CA1CA2NPC1
SCHEMBL21219242 0.82 AURKA (0.48) CYP3A4CYP2C19CA1CA2NPC1
SCHEMBL7378493 0.81 NPC1 (0.48) CYP3A4CYP2C19CA1CA2NPC1
SCHEMBL6691001 0.81 CYP4F2 (0.51) CYP3A4CYP2C19AURKARPS6KB1SIRT2
SCHEMBL23093001 0.81 KCNQ4 (0.39) CA1CA2SMN1; SMN2MMP1MMP2
SCHEMBL8214435 0.80 CYP3A4 (0.48) CYP3A4CYP2C19CA1CA2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 — — US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 — — EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 — — WO disclosed
Send feedback